Here we report on the formation and activity of complexes between the large subunit (mR1) dimer of mouse ribonucleotide reductase (mRR) and small subunit chimeric dimers (cR2) derived from Escherichia coli and mouse small subunits. cR2 subunits were constructed by substituting mouse C-terminal gene sequences, coding for either 7 or 33 amino acid residues, for the corresponding E.coli R2 (eR2) sequences, with the remainder of the gene corresponding to eR2. The purified cR2s contained the µ-oxo bridged diferric center and tyrosine radical necessary for reductase activity, although the radical signal was broadened compared with wild-type eR2. Neither chimera formed an active complex with mR1, but each was a competitive inhibitor, with respect to mR2, of mRR activity. The inhibition constants for both chimeras were similar, and were sevenfold higher than the dissociation constant of mR2 dimer to mR1 dimer (0.24⍨0.02 µM). Analysis of inhibition data showed that chimeric R2 subunits bind to mammalian R1 with a 1:1 (R1:R2) stoichiometry and permit the inference that both C-termini in a cR2 dimer bind to the two sites per mR1 dimer. The lack of enzymatic activity in the mR1-cR2 complex is attributed to perturbation or elimination of interactions linking the tyrosine radical/dinuclear iron center and the C-terminus within R2.
Introduction
Type 1 ribonucleotide reductases (RR), such as those isolated from mammalian, viral, and some bacterial (e.g. E.coli) and protozoan sources are composed of two homodimeric subunits, R1 2 and R2 2 . The larger subunit R1 contains binding sites for substrates and allosteric effectors, whereas the smaller subunit R2 contains a µ-oxo bridged diferric center, neighboring a stable tyrosyl radical. Formation of the R1 2 -R2 2 complex is essential for enzymatic activity (Erikson and Sjöberg, 1989; Stubbe, 1990) . Such activity is thought to proceed via a transfer of free radical character from the tyrosyl radical in R2 to the substrate bound to R1, over a distance estimated as 35 Å (Uhlin and Eklund, 1994) .
Several laboratories have demonstrated that type 1 RRs are inhibited by peptides corresponding to the C-terminus of R2, which compete with R2 for binding to R1 (Cohen et al., 1986; Dutia et al., 1986; McClements et al., 1988; Yang et al., 1990; Cosentino et al., 1991) . The N-acetylated C-terminal heptapeptide in mammalian R2 (mR2), N-AcFTLDADF, provides the minimal length necessary for inhibition of eucaryotic RRs , consistent with a high degree of homology displayed among the seven C-terminal residues of eucaryotic R2s. Structure-function studies show high specificity at some positions within the terminal heptamer for binding to mammalian R1 (mR1), and the observed pattern is well explained by recent NMR determinations of the structure of the C-terminal peptide bound to mR1 (Fisher et al., 1995; Laub,P.B., Fisher,A.L., Furst,G. T., Barwis,B.S., Hamann,C.S. and Cooperman,B.S., in preparation). Escherichia coli R2 (eR2) does not form an enzymatically active complex with mR1, as expected given that its R2 C-terminal sequence is quite different from that of mR2.
R2 may be considered as a cofactor in the RR holoenzyme (Stubbe and van der Donk, 1995) , supplying the necessary radical in much the same way that thiamine pyrophosphate supplies carbanion character in thiamine pyrophosphate-requiring enzymes, except over a larger distance. In the simplest form of this model, it should suffice to bring a stable tyrosyl radical within an appropriate distance from the R1 substrate site to achieve enzymatic activity. To test this model, we constructed, expressed and purified chimeric R2 proteins in which C-terminal sequences in eR2 are replaced by C-terminal sequences of seven and 33 residues in length, respectively, from the mR2 subunit. These two chimeric proteins, c 7 R2 and c 33 R2, contain the two regions of an R2 known to be necessary for generating RR catalytic activity: the diferric center/tyrosyl radical and the mouse C-terminal region required for binding to mR1. Here we report on the binding and catalytic activity of these two chimeric proteins when added to mR1. H]CDP was purchased from Amersham. Aminophenylboronate-agarose and protein concentration membranes were from Amicon. DEAE-agarose was from Bio-Rad. FAST-Q was from Pharmacia. DTT, BSA, ampicillin (sodium salt) and Dowex-1-Chloride were from Sigma. Bacto-tryptone and yeast extract (Difco) were from Thomas Scientific. The N-acylated peptide AcFTLDADF was previously synthesized in our laboratory (Yang et al., 1990) . Escherichia coli and mouse RRs Escherichia coli R1 (eR1) and eR2 were gifts from Professor J.Stubbe (MIT). Cloned mR1 was purified from the mouse gene expressed in a baculovirus system . mR2 was prepared from an E.coli strain containing the pET-M2 plasmid encoding mR2, a gift of Professor L. Thelander (University of Umeå; Mann et al., 1991) . 
Materials and methods

Materials
Construction of plasmids encoding chimeric small subunit proteins
Primers used in these constructions are presented in Figure 1 . Plasmids encoding the chimeric R2 subunits c 7 R2 and c 33 R2 were constructed by PCR. Primers A and B and nrdB DNA (from the plasmid pSPS2, which was a gift from Professor Stubbe) were used for the c 7 R2 plasmid. The plasmid encoding c 33 R2 was constructed in two steps. The eR2 portion was obtained by PCR using primers A and C; this corresponds to amino acid residues -1 to 343 of the eR2 sequence. The Cterminal region was synthesized from primers D and E; this corresponds to residues 341-343 of eR2 and the first nine of 33 C-terminal amino acids of mR2. The products of these two reactions were mixed and re-amplified using primers A and E to produce the desired c 33 R2 gene product. The sequences of the double-stranded DNAs encoding the c7R2 and c33R2 proteins were determined using dye terminators followed by automated sequencing (ABI Prism). They corresponded precisely to the desired fusion of the E.coli and mouse R2 genes (Carlson et al., 1984; Thelander and Thelander, 1989) with no spurious mutations.
Both final PCR products contain XbaI restriction sites inframe at both termini to facilitate cloning into the expression vector pZM-S .
Bacterial cell growth
Cultures of bacteria containing the plasmid encoding c 7 R2 or c 33 R2 were grown at 30°C in LB medium (per liter: 10 g bacto-tryptone, 10 g NaCl, 5 g yeast extract) containing 50 µg/ml ampicillin. When A 600 reached 0.14-0.16 plasmid expression was induced by a temperature jump to 42°C in less than 5 min, using a steam coil. Cells were grown for an additional 4 h at 42°C to an A 600 of 0.7-0.8, then chilled on ice and harvested by centrifugation. Expression and purification of chimeric small subunit proteins Each construct was expressed efficiently, as shown by SDS-PAGE analysis of total cell extract ( Figure 2A ). c 7 R2 was . Western blot analysis was performed with antibody raised to a malarial R-mouse R2 fusion protein, composed of amino acids 50-264 of Plasmodium falciparum R2 and the seven C-terminal amino acid residues of mouse R2 , that has no reactivity toward eR2. prepared analogously to eR2 according to Salowe and Stubbe (1986) with the following modifications. After loading the desalted protein mixture from 10 g of cells onto the DEAEagarose column (2.5cmϫ16cm, 1 ml/min), the column was washed with Tris buffer (50 mM Tris-HCl, pH 7.6, 5% glycerol) until the A 280 ഛ0.4, then washed with Tris buffer containing 100 mM NaCl to remove contaminating protein that exhibited a broad peak at 410 nm. When the c 7 R2 began to elute (as evidenced by the characteristic A 325 -A 425 spectrum) the buffer was changed to Tris containing 150 mM NaCl. Radical-containing fractions were pooled and concentrated using an Amicon concentrator with a 30 kDa cut-off filter. c 33 R2 was prepared similarly to c 7 R2, except that it elutes from the DEAE-agarose column in somewhat lower salt. Furthermore, whereas c 7 R2 showed no evidence of contamination with C-terminal clipped protein (Sahlin et al., 1987) and was adequately purified as described, c 33 R2 required a further chromatography on FAST-Q [50 mM Tris-HCl, pH 7.6, and a 50-450 mM NaCl gradient, following Sjöberg et al. (1987) ] to remove C-terminal truncated protein, both singly-and doubly-clipped dimer ( Figure 2B and C), which together represented some 40% of the DEAE-agarose eluate. Typical purification and regeneration gave net yields of 3.8 mg c 7 R2/g wet cells and 2.8 mg c 33 R2/g wet cells. The proteins were Ͼ80% pure as determined by SDS-PAGE (Figure 2A , lanes 6 and 7). Methods Spectroscopy Uv-Vis spectra were recorded on a Hewlett-Packard 8452A Diode-array Spectrophotometer. EPR Spectra were recorded on a Varian E-109 spectrometer with a 10-inch magnet. Temperature was determined with a thermocouple located just below the sample and maintained at 20-30 K using a heliumflow variable temperature cryostat (Air Products and Chemicals, Inc.). CD spectra were recorded on an AVIV 60DS spectrometer.
Protein concentrations were determined by the method of Bradford (1976) , using BSA as standard. SDS-PAGE was run according to Laemmli (1970) .
Radical regeneration and quantitation
Both c 7 R2 and c 33 R2 were regenerated using the ferrous ascorbate method as described (Atkin et al., 1973) . Tyrosyl radical content was estimated by Uv-Vis spectrometry, using the 'dropline 412' (D 412 ), as defined by equation [1] , a molar extinction coefficient of 3900 M -1 cm -1 and a molecular mass for the deduced sequence of 43.5 kDa (Stubbe, 1990) . In agreement with previous results for E.coli R2 (Bollinger et al., 1991) , radical content estimated by D 412 and by EPR signal intensity were equivalent.
(1) Enzyme assays Standard RR activity assays were carried out as previously described (Yang et al., 1990) . Either the Dowex-1-borate method of Steeper and Steuart (1970) , or the aminophenylboronate method of Moore et al. (1974) , were used to separate deoxycytidine or dCDP from cytidine or CDP, respectively, with equivalent results. Assays were run at 37°C. The reaction mixture contained, in a final volume of 70 µl, 60 mM HEPES, pH 7.6, 2.7 mM MgAc 2 , 8.75 mM NaF, 25 mM DTT, 0.05 mM FeCl 3 , 3 mM ATP, 150 µM BSA and 0.03 mM [5-3 H]CDP (45 Ci/mol). Typical subunit concentrations were mR1 2 , 0.1 µM; mR2 2 , 0.03-0.3 µM. DTT, ATP, CDP and FeCl 3 were all present in saturating amounts. BSA was added to keep protein concentration constant, thus suppressing nonspecific activation effects resulting from R1 or R2 addition. Under these conditions, activity was constant for at least 40 min. Reactions were quenched in boiling water for 5 min. Samples were lyophilized to dryness before chromatography, to reduce tritium background, which varied from 0.5-1.5% of total radioactivity.
Assays attempting to measure RR activity on addition of chimera R2 to R1 employed higher specific radioactivity ([5-3 H]CDP, 20 Ci/mmol), higher concentrations of protein [c 7 R2 or c 33 R2 (3.3 µM), mR1 (8-16 µM)] and 30 min incubation times.
The specific activities of the subunits used in this work were 100-200 U for mR1 (measured at saturating mR2), and 200-300 U for mR2 (measured at saturating mR1), where 1 unit is defined as 1 nmol dCDP formed/(minϫmg of protein). Calculations Equations 2-6, previously derived for eR2 and peptide binding to eR1 (Climent et al., 1991) , were used to analyze chimera Fig. 3 . Amino acid sequence alignment of the C-terminal regions of eR2, mR2, c 7 R2 and c 33 R2. The asterisk (*) and caret ( ∧ ) indicate fusion points of c 7 R2 and c 33 R2, respectively. Conserved residues are in bold; residues in the proposed electron transfer pathway are underlined. Adapted from Climent et al. (1991) . Numbering refers to the E.coli sequence.
and peptide inhibition of RR activity, where 
for 1:1 mR1:inhibitor binding:
for 1:2 mR1:inhibitor binding:
Results and discussion
Expression, characterization and radical regeneration of chimeric R2s
Chimeric R2 genes were constructed by fusing mouse Cterminal sequences, coding for either seven or 33 residues, with E.coli R2 sequences coding for residues -1 to 365 or -1 to 343, respectively. The relevant amino acid sequences are presented in Figure 3 . CD spectra for eR2, c 7 R2 and c 33 R2 in the range 200-250 nm were essentially identical, as were Uv-Vis spectra (300-500 nm), each protein showing the characteristic peak for tyrosyl radical absorption at 412 nm (and shoulder at 390 nm), as well as the broad maxima at 325 and 370 nm corresponding to the iron center (data not shown). The regeneration system of Atkin et al. (1973) was used to increase radical content. As measured by D 412 , radical contents per dimer before and after regeneration were 1.5, 1.0; 0.7, 1.0; and 0.6, 0.8 for eR2, c 7 R2 and c 33 R2, respectively.
The EPR spectra c 7 R2 and c 33 R2 (Figure 4) showed the characteristic doublet of the tyrosyl radical signal centered at g ϭ 2.0047 (Ehrenberg and Reichard, 1972; Reichard and Ehrenberg, 1983) . Both spectra were broadened as compared with the spectrum of eR2, with the broadening of c 33 R2 being more marked. These changes presumably reflect perturbations in the geometry of the tyrosyl radical/dinuclear iron center (Sahlin et al., 1987) . They support the earlier suggestion (Filatov et al., 1992) of a direct structural link between this center and the C-terminus of R2, based on the observation of a similarly broadened EPR spectrum for truncated HSV-R2 lacking the seven C-terminal amino acid residues.
The effects of c 7 R2 and c 33 R2 on CDP reductase activity
No measurable CDP reductase activity was found on addition of either c 7 R2 or c 33 R2 to mR1, even employing assay conditions that were sufficient to detect the very low levels of activity (0.5% compared with wild-type) we observed for the Y177F-mR2 variant (Henriksen et al., 1994) . Failure to detect reaction under these conditions allows us to estimate the specific activity of either mR1-cR2 complex as Ͻ0.03% that of mR1-mR2 complex.
On the other hand, both c 7 R2 and c 33 R2 inhibited the CDP reductase activity of the mR1-mR2 complex ( Figure 5 ). These results were analyzed as reflecting competition by cR2 dimer (cR2 2 ) for the binding of mR2 2 to mR1 2 , according to equations 2-5, yielding the parameter values presented in Table I . The value for K d (0.24 Ϯ 0.02 µM), the dissociation constant for the mR1 2 -mR2 2 complex, is similar to values (0.17 µM, Rova et al., 1995; 0.52 Ϯ 0.20 µM, Ingemarson and Thelander, 1996) determined using biosensor analysis.
The corresponding dissociation constants for c 7 R2 and c 33 R2, 1.8-1.9 µM, are considerably higher. This raised the question as to whether both C-termini in a cR2 dimer bind simultaneously to the two binding sites in the mR1 dimer, as they presumably do in the mR2 dimer (see below), or whether one mR1 dimer might be complexed with up to two cR2 dimers, each binding to a single site in mR1 2 . Ligands binding to mR1 2 with a maximum stoichiometry of 1:1 or 2:1 differ in the predicted dependencies of K app /K d on inhibitor concentration (equations 5 and 6). The relevant plots ( Figure 6B and C) clearly demonstrate a 1:1 stoichiometry for the binding of either c 7 R 2 or c 33 R 2 to mR1 2 . By comparison, inhibition studies with the acetylated mR2 C-terminal peptide AcFTLDADF ( Figure 5 ) resulted in a dependence of K app /K d on inhibitor concentration reflecting a maximum stoichiometry of two, as expected ( Figure 6A ). The value of K p (18.5 µM), calculated according to equations 6 assuming that the intrinsic dissociation constant of AcFTLD-ADF is the same to each of the two identical sites on mR1, is consistent with earlier results (Yang et al., 1990; Fisher et al., 1993) . The validity of the assumption of identical sites was demonstrated by replotting the data in Figure 6A as described by Climent et al. (1991) . Thus, plots of (a) [peptide] -1 gave a straight line with a y-intercept near zero (0.05), consistent both with a lack of interaction between the two bound peptides and the competitive nature of the inhibition with respect to R2. mR2 2 binds to mR1 2 some 80-fold more tightly than AcFTLDADF, presumably reflecting a chelating effect due to the dual contacts afforded by dimer-dimer complexation, as has also been described for eR2 2 binding to eR1 2 (Climent et al., 1991 (Climent et al., , 1992 . However, formation of the second contact is energetically much less favorable than formation of the first. The additivity of binding energies for a multisite system may 223 be described in terms of unitary free energy, ∆Gu, equal to -RT lnK a (Chipman and Sharon, 1969) , where K a is in units of mole fractions. We assume that the free energy release associated with the binding of the first mR2 C-terminus to mR1 2 is well approximated by that associated with the binding of AcFTLDADF to mR1 2 . Based on a K p value of 18.6 µM (Table I) , this corresponds to a ∆Gu of -9.2 kcal/mol. By comparison, ∆Gu for mR2 2 binding, based on a K d value of 0.24 µM, is -11.9 kcal/mol, leading to an estimated value of -2.7 kcal/mol for the free energy change associated with the binding of the second mR2 terminus to mR1 2 . Formally, this value has to be considered as an upper limit, since its magnitude would be decreased to the extent that a region of mR2 outside the C-terminus participated in stabilizing the R1-R2 complex. However, at least in the case of eRR, Climent and co-workers (1992) have presented cogent evidence that such participation must be quite limited.
The necessary conclusion is that the two C-termini in mR2 2 are not positioned for optimal contact with mR1 2 . Either the mR1 2 -mR2 2 complex is asymmetric, with one strong and one weak R1-R2 contact, or it is symmetric, with weaker contacts made at each R1-R2 interface than those seen for R2 Cterminal peptide binding to R1 (Uhlin and Eklund, 1994; Fisher et al., 1995; Laub,P.B., Fisher,A.L., Furst,G. T., Barwis,B.S., Hamann,C.S. and Cooperman,B.S., in preparation. The eight-fold higher dissociation constant for mR1 2 binding to cR2 2 versus mR2 2 is then easily accounted for if the scaffold offered by eR2 2 is a somewhat poorer fit for dual contact with mR1 2 than that offered by mR2 2 .
The dissociation constant for mR1 2 binding to cR2 2 is still 10 times lower than what is found for AcFTLDADF (Table I) , and five times lower than what would be expected if cR2 2 bound via a single peptide contact to mR1 2 , indicating, along with the evidence for 1:1 complex formation, that dual contact is retained in the mR1 2 -cR2 2 complexes. However, formation of a dual contact complex between mR1 2 and a properly folded R2 dimer (Ͼ80% of each chimera was complexed to mR1 under the assay conditions employed), containing the necessary tyrosine radical and dinuclear iron center, is not sufficient for generation of enzymatic activity. Rather, our present results suggest a dual function for the extreme C-terminus (last seven residues) of R2, not only forming the contact with R1 but also forming a discrete link in the long range electron transfer pathway between the tyrosine radical and the enzymatic active site on R1.
Electron transfer between the Tyr radical and the substrate site in R1 is thought to proceed via a precise route involving specific amino acids (Rova et al., 1995) based on the loss of enzymatic activity following site-specific mutation of highly conserved residues in both eR2 and mR2 (Climent et al., 1992; Regnström et al., 1994; Ormo et al., 1995; Rova et al., 1995; Henriksen,M.A. and Cooperman,B.S., in preparation) . The residue closest to the C-terminus that has been directly implicated is the final tyrosine in R2, Y356 in eR2 (Climent et al., 1992) and the aligned Y370 in mR2 (Henriksen,M.A. and Cooperman,B.S., in preparation) , positioned some 20 residues from the C-terminal end (Figure 3) . The lack of enzymatic activity in the mR1 2 -cR2 2 complexes and the EPR results discussed above lead us to speculate that one or more of the terminal seven residues (positions 384-390 in mR2) also participates in the electron transfer route. If this were so, enzymatic activity would be very sensitive to interactions linking the tyrosine radical/dinuclear iron center and the seven R2 C-terminal residues within the R1 2 -R2 2 complex, so that elimination and/or perturbation of these interactions, as would necessarily occur within each cR2, would account for the lack of enzymatic activity in the mR1 2 -cR2 2 complexes. This speculation leads to the prediction that it may be possible to decouple the postulated two R2 C-terminal functions by preparing variant mR2s mutated within the terminal seven residues that retain essentially full binding activity for mR1 but are enzymatically inactive. Experiments are underway to test this prediction.
